Novartis’ Entresto Heart Failure Treatment Closer to European Approval
Novartis recently announced that Entresto (sacubitril/valsartan) has received a positive opinion from the European Committee for Medicinal Products for Human Use (CHMP). The decision is an important step in Entresto becoming available ... Read more